Twitter LinkedIn
    Monday, June 5
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»CVC Capital Partners Is Said to Near $2.6 Billion Deal for Pharma Firm Cooper
    Deals & Transactions

    CVC Capital Partners Is Said to Near $2.6 Billion Deal for Pharma Firm Cooper

    March 10, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    CVC Capital Partners
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    CVC Capital Partners is nearing a deal to acquire European over-the-counter drugmaker Cooper for about 2.2 billion euros ($2.6 billion), people familiar with the matter said. The private equity firm is negotiating detailed terms of an agreement with Cooper’s owner, Charterhouse Capital Partners, according to the people.

    CVC beat out rival suitors including a consortium led by PAI Partners, the people said, asking not to be identified because the information is private. No final agreements have been signed yet, and talks could still fall apart, the people said. Representatives for Charterhouse, CVC and PAI declined to comment.

    A deal would add to almost $11 billion of health-care acquisitions by private equity firms in Europe so far in 2021, a figure that’s up more than 700% year-on-year, according to data compiled by Bloomberg. Charterhouse bought Cooper in 2015.

     

    Read More

    Source: BNN Bloomberg

    By Manuel Baigorri, Jan-Henrik Förster and Myriam Balezou

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Acquisitions Buyouts deals Investments
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Animal drugs maker Dechra agrees to lower £4.5bn takeover by Swedish private equity firm EQT

    June 3, 2023

    Warburg and Advent in the lead to acquire Baxter’s biopharma unit

    May 13, 2023

    BlackRock Sells Asset-Backed Bonds From Credit Suisse’s Books

    April 14, 2023

    KKR buys stake in communications firm FGS Global

    April 11, 2023

    Comments are closed.

    Other Articles

    OakNorth Bank makes new hires in the North West, Yorkshire and East Anglia

    April 16, 2021

    CAPZA acquires a majority stake in Eidosmedia

    May 5, 2021

    Clearlake & TA Associates-Backed Precisely to Acquire Winshuttle

    June 20, 2021

    Plexus Capital Raises More Than $200 Million for Inaugural Buyout Equity Fund

    May 9, 2022

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?